labetalol has been researched along with Eye Manifestations in 1 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Eye Manifestations: Ocular disorders attendant upon non-ocular disease or injury.
| Excerpt | Relevance | Reference |
|---|---|---|
| "1 In nine hypertensive subjects with angina pectoris, labetalol diminished the incidence of chest pain occurring spontaneously or induced by exercise." | 7.66 | Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients. ( Besterman, EM; Spencer, M, 1979) |
| "1 In nine hypertensive subjects with angina pectoris, labetalol diminished the incidence of chest pain occurring spontaneously or induced by exercise." | 3.66 | Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients. ( Besterman, EM; Spencer, M, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Besterman, EM | 1 |
| Spencer, M | 1 |
1 other study available for labetalol and Eye Manifestations
| Article | Year |
|---|---|
Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.
Topics: Angina Pectoris; Blood Pressure; Electrocardiography; Ethanolamines; Eye Manifestations; Female; Hea | 1979 |